|1.||Gerhardt, Robert T: 1 article (08/2013)|
|2.||Convertino, Victor A: 1 article (08/2013)|
|3.||Metzger, Anja: 1 article (08/2013)|
|4.||Segal, Nicolas: 1 article (08/2013)|
|5.||Lurie, Keith G: 1 article (08/2013)|
|6.||McKnite, Scott: 1 article (08/2013)|
|7.||Rees, Jennifer: 1 article (08/2013)|
|8.||Matsuura, Timothy: 1 article (08/2013)|
|9.||Kumasawa, Keiichi: 1 article (01/2012)|
|10.||Koyama, Shinsuke: 1 article (01/2012)|
10/01/2006 - "Hypoxia was assessed with NITP (7-(4'-(2-nitroimidazol-1-yl)-butyl)-theophylline). "
12/01/1995 - "However, the bound metabolites of NITP within tumours were localised to the injection site, suggesting that direct injection is unlikely to be a useful method of administering bioreductive hypoxia markers. "
12/01/1995 - "Pharmacokinetics and binding of the bioreductive probe for hypoxia, NITP: effect of route of administration."
04/01/1995 - "Potential bioreductively activated hypoxia probes and post-irradiation radiosensitizers related to NITP."
12/01/1995 - "The data in this paper demonstrate that bound metabolites of the hypoxia marker NITP can be detected in tumours following oral administration of an aqueous formulation of NITP, and suggest that oral administration could be a satisfactory administration route for clinical studies with NITP."
|3.||Airway Obstruction (Choking)
04/01/1988 - "This study evaluated the effects of NITP with and without airway obstruction confined to early (ED), mid- (MD), or late diastole (LD) on the subsequent LVSV, anteroposterior (AP), and right-to-left (RL) aortic diameters (DAO) (series I, n = 6) as well as on phasic arterial blood flow out of the thorax (series II, n = 6) in anesthetized dogs. "
06/01/2006 - "They were classified into primary AITP (P-AITP) (n=21), secondary AITP (S-AITP) (n=15), and non-immune thrombocytopenia (NITP) (n=21) by bone marrow findings and clinical diagnosis. "
09/01/2002 - "Isoimmunization against CD36 can cause neonatal isoimmune thrombocytopenia (NITP), refractoriness to platelet transfusions, and post-transfusion purpura. "
10/01/2002 - "Forty-two patients had primary ITP (P-ITP), 23 patients had ITP secondary to other immune diseases (S-ITP) and 39 patients had thrombocytopenia due to decreased platelet production (non-immune; NITP). "
06/01/1992 - "A reduction in the size of the shoulder of the survival curve should allow the hypoxic-cell radiosensitizing efficiency of NITP to be maintained with low doses of radiation used in multifraction cancer radiotherapy. "
09/01/2000 - "Both NITP and pimonidazole stained the same hypoxic tumor areas. "
01/01/2000 - "De novo cancers in paediatric renal transplant recipients: a multicentre analysis within the North Italy Transplant programme (NITp), Italy."
|1.||DNA (Deoxyribonucleic Acid)
|2.||Inosine Triphosphate (ITP)
|3.||HOE 33342 (Hoechst 33342)
|2.||Heterologous Transplantation (Xenotransplantation)
|4.||Platelet Transfusion (Blood Platelet Transfusions)
|5.||Transplantation (Transplant Recipients)